| __timestamp | Agios Pharmaceuticals, Inc. | Catalyst Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 19120000 | 4473654 |
| Thursday, January 1, 2015 | 35992000 | 8597010 |
| Friday, January 1, 2016 | 50714000 | 7910260 |
| Sunday, January 1, 2017 | 71124000 | 7304399 |
| Monday, January 1, 2018 | 114145000 | 15875961 |
| Tuesday, January 1, 2019 | 132034000 | 36881187 |
| Wednesday, January 1, 2020 | 149070000 | 44233754 |
| Friday, January 1, 2021 | 121445000 | 49628000 |
| Saturday, January 1, 2022 | 121673000 | 58183000 |
| Sunday, January 1, 2023 | 119903000 | 133710000 |
| Monday, January 1, 2024 | 156784000 |
Unveiling the hidden dimensions of data
In the competitive world of biotechnology, managing operational expenses is crucial for sustained growth. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Catalyst Pharmaceuticals, Inc. and Agios Pharmaceuticals, Inc. over the past decade.
From 2014 to 2023, Agios Pharmaceuticals consistently reported higher SG&A expenses, peaking in 2020 with a 680% increase from 2014. In contrast, Catalyst Pharmaceuticals demonstrated a more conservative approach, with a notable surge in 2023, marking a 2,890% increase from their 2014 figures.
Agios's higher SG&A spending reflects its aggressive market expansion and R&D investments, while Catalyst's recent spike suggests a strategic pivot towards growth. Understanding these trends offers valuable insights into each company's operational priorities and market strategies.
Cost Management Insights: SG&A Expenses for Amgen Inc. and Agios Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing BioMarin Pharmaceutical Inc. and Agios Pharmaceuticals, Inc.
Sarepta Therapeutics, Inc. vs Catalyst Pharmaceuticals, Inc.: SG&A Expense Trends
Grifols, S.A. and Agios Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Ionis Pharmaceuticals, Inc. or Catalyst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? CymaBay Therapeutics, Inc. or Agios Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: Vericel Corporation vs Agios Pharmaceuticals, Inc.
Comparing SG&A Expenses: Catalyst Pharmaceuticals, Inc. vs Galapagos NV Trends and Insights
Comparing SG&A Expenses: Catalyst Pharmaceuticals, Inc. vs Xencor, Inc. Trends and Insights
Breaking Down SG&A Expenses: Agios Pharmaceuticals, Inc. vs Geron Corporation
Agios Pharmaceuticals, Inc. vs Novavax, Inc.: SG&A Expense Trends
Operational Costs Compared: SG&A Analysis of Agios Pharmaceuticals, Inc. and Viridian Therapeutics, Inc.